Cargando…
Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
BACKGROUND: Fibroblast growth factor (FGF)‐23 is increased first in the sequence of changes associated with chronic kidney disease (CKD)‐mineral and bone disorder. Thus, its measurement may serve as a predictive indicator of incident hyperphosphatemia. OBJECTIVES: To investigate whether serum FGF‐23...
Autores principales: | Miyakawa, Hirosumi, Hsu, Huai‐Hsun, Ogawa, Mizuki, Akabane, Ryota, Miyagawa, Yuichi, Takemura, Naoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478064/ https://www.ncbi.nlm.nih.gov/pubmed/34418162 http://dx.doi.org/10.1111/jvim.16237 |
Ejemplares similares
-
Assessment of the measurement of canine and feline serum fibroblast growth
factor-23 concentrations by automated chemiluminescence immunoassay
por: MIYAKAWA, Hirosumi, et al.
Publicado: (2021) -
A dog presenting with syncope due to two different etiologies
por: Ogawa, Mizuki, et al.
Publicado: (2022) -
Serum cystatin C concentration can be used to evaluate glomerular filtration rate in small dogs
por: MIYAGAWA, Yuichi, et al.
Publicado: (2020) -
Effects of ivabradine and atenolol on heart rate and heart rate variability in healthy cats over a 24 h period: A pilot study
por: Ogawa, Mizuki, et al.
Publicado: (2022) -
Evaluation of the association between electrocardiogram parameters and left cardiac remodeling in dogs with myxomatous mitral valve disease
por: Ogawa, Mizuki, et al.
Publicado: (2022)